Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:ARA

American Renal Associates (ARA) Stock Price, News & Analysis

American Renal Associates logo

About American Renal Associates Stock (NYSE:ARA)

Advanced Chart

Key Stats

Today's Range
$11.33
$11.52
50-Day Range
$11.46
$11.52
52-Week Range
$5.57
$11.98
Volume
9,831 shs
Average Volume
106,940 shs
Market Capitalization
$397.94 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ARA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for American Renal Associates and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ARA Stock News Headlines

Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.tc pixel
American Renal Associates Holdings, Inc. News
See More Headlines

ARA Stock Analysis - Frequently Asked Questions

American Renal Associates Holdings, Inc. (NYSE:ARA) announced its quarterly earnings data on Wednesday, November, 11th. The company reported $0.15 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.06 by $0.09. The business earned $209.69 million during the quarter, compared to analysts' expectations of $211.50 million. American Renal Associates had a negative trailing twelve-month return on equity of 3.56% and a negative net margin of 2.04%.

American Renal Associates (ARA) raised $161 million in an initial public offering (IPO) on Thursday, April 21st 2016. The company issued 7,500,000 shares at $20.00-$23.00 per share. BofA Merrill Lynch, Barclays and Goldman Sachs served as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey and Leerink Partners were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that American Renal Associates investors own include Zevra Therapeutics (KMPH), Madrigal Pharmaceuticals (MDGL), Exelixis (EXEL), Gilead Sciences (GILD), Spectrum Pharmaceuticals (SPPI), AbbVie (ABBV) and Bristol Myers Squibb (BMY).

Company Calendar

Last Earnings
11/11/2020
Today
8/28/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Miscellaneous Health & Allied Services
Sub-Industry
N/A
Current Symbol
NYSE:ARA
CIK
1498068
Fax
N/A
Employees
4,977
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$0.26
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$13.79 million
Net Margins
-2.04%
Pretax Margin
N/A
Return on Equity
-3.56%
Return on Assets
-0.24%

Debt

Debt-to-Equity Ratio
7.54
Current Ratio
1.05
Quick Ratio
1.02

Sales & Book Value

Annual Sales
$822.52 million
Price / Sales
0.48
Cash Flow
$1.69 per share
Price / Cash Flow
6.80
Book Value
$2.59 per share
Price / Book
4.45

Miscellaneous

Outstanding Shares
34,543,000
Free Float
N/A
Market Cap
$397.94 million
Optionable
Optionable
Beta
1.11
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NYSE:ARA) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners